Edwards Lifesciences Corporation Operating Cash Flow
Edwards Lifesciences Corporation (EW) reported Operating Cash Flow of $695.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $651.90M, a 124.64% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $43.80M, a 84.38% decline year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $450.90M.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $573.70M, a 63.08% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for fiscal 2025 was $1.60B, a 194.15% increase from fiscal 2024.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for fiscal 2024 was $542.30M, a 39.46% decline from fiscal 2023.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for fiscal 2023 was $895.80M, a 26.47% decline from fiscal 2022.
- Edwards Lifesciences Corporation net cash provided by (used in) operating activities for fiscal 2022 was $1.22B, a 29.67% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $651.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $695.70M 10-Q · filed 2026-08-04 | $1.15B derived: sum of 3 quarters · filed 2026-08-04 | $1.72B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $43.80M 10-Q · filed 2026-05-06 | $494.70M derived: sum of 2 quarters · filed 2026-05-06 | $1.07B derived: sum of 3 quarters · filed 2026-05-06 | $1.36B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $450.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.02B derived: sum of 2 quarters · filed 2026-02-25 | $1.31B derived: sum of 3 quarters · filed 2026-08-04 | $1.60B 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $573.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $863.90M derived: sum of 2 quarters · filed 2026-08-04 | $1.14B 10-Q · filed 2025-11-05 | $1.02B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $290.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $570.60M 10-Q · filed 2026-08-04 | $443.10M derived: sum of 3 quarters · filed 2026-08-04 | $794.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $280.40M 10-Q · filed 2026-05-06 | $152.90M derived: sum of 2 quarters · filed 2026-05-06 | $504.70M derived: sum of 3 quarters · filed 2026-05-06 | $876.20M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$127.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $224.30M derived: sum of 2 quarters · filed 2026-02-25 | $595.80M derived: sum of 3 quarters · filed 2026-02-25 | $542.30M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $351.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $723.30M derived: sum of 2 quarters · filed 2025-11-05 | $669.80M 10-Q · filed 2025-11-05 | $806.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $371.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $318.00M 10-Q · filed 2025-08-06 | $454.60M derived: sum of 3 quarters · filed 2026-02-25 | $866.10M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$53.50M 10-Q · filed 2025-05-06 | $83.10M derived: sum of 2 quarters · filed 2026-02-25 | $494.60M derived: sum of 3 quarters · filed 2026-02-25 | $528.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $136.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $548.10M derived: sum of 2 quarters · filed 2026-02-25 | $581.70M derived: sum of 3 quarters · filed 2026-02-25 | $895.80M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $411.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $445.10M derived: sum of 2 quarters · filed 2024-11-06 | $759.20M 10-Q · filed 2024-11-06 | $1.04B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $347.70M 10-Q · filed 2024-07-31 | $630.50M derived: sum of 3 quarters · filed 2025-02-28 | $940.40M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $314.10M 10-Q · filed 2024-04-29 | $596.90M derived: sum of 2 quarters · filed 2025-02-28 | $906.80M derived: sum of 3 quarters · filed 2025-02-28 | $1.24B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $282.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $592.70M derived: sum of 2 quarters · filed 2025-02-28 | $924.90M derived: sum of 3 quarters · filed 2025-02-28 | $1.22B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $309.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $642.10M derived: sum of 2 quarters · filed 2023-10-27 | $935.40M 10-Q · filed 2023-10-27 | $1.31B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $332.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $625.50M 10-Q · filed 2023-07-28 | $999.10M derived: sum of 3 quarters · filed 2024-02-12 | $1.53B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $293.30M 10-Q · filed 2023-04-28 | $666.90M derived: sum of 2 quarters · filed 2024-02-12 | $1.20B derived: sum of 3 quarters · filed 2024-02-12 | $1.72B derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $373.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $905.50M derived: sum of 2 quarters · filed 2024-02-12 | $1.43B derived: sum of 3 quarters · filed 2024-02-12 | $1.73B 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $531.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $1.06B derived: sum of 2 quarters · filed 2022-10-28 | $1.36B 10-Q · filed 2022-10-28 | $1.76B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $526.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $826.60M 10-Q · filed 2022-07-29 | $1.23B derived: sum of 3 quarters · filed 2023-02-13 | $1.44B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $300.50M 10-Q · filed 2022-04-28 | $700.30M derived: sum of 2 quarters · filed 2023-02-13 | $916.40M derived: sum of 3 quarters · filed 2023-02-13 | $1.15B derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $399.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $615.90M derived: sum of 2 quarters · filed 2023-02-13 | $847.20M derived: sum of 3 quarters · filed 2023-02-13 | $1.05B 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $216.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $447.40M derived: sum of 2 quarters · filed 2021-10-29 | $654.50M 10-Q · filed 2021-10-29 | $654.30M 10-Q · filed 2020-10-26 | $1.06B derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-06-30 | $231.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $438.40M 10-Q · filed 2021-07-30 | $438.20M 10-Q · filed 2020-07-27 | $841.30M derived: sum of 3 quarters · filed 2022-02-14 | $1.28B derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-03-31 | $207.10M 10-Q · filed 2021-04-28 | $207.00M 10-Q · filed 2020-04-28 | $610.00M derived: sum of 2 quarters · filed 2022-02-14 | $1.05B derived: sum of 3 quarters · filed 2022-02-14 | $1.39B derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2019-12-31 | $402.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $840.20M derived: sum of 2 quarters · filed 2022-02-14 | $1.18B derived: sum of 3 quarters · filed 2022-02-14 | $1.18B 10-K · filed 2022-02-14 | $1.18B 10-K · filed 2020-02-14 | |||
| 2019-09-30 | $437.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $778.50M derived: sum of 2 quarters · filed 2020-10-26 | $780.00M 10-Q · filed 2020-10-26 | $1.07B derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $341.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $342.70M 10-Q · filed 2020-07-27 | $635.60M derived: sum of 3 quarters · filed 2021-02-12 | $977.90M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $1.50M 10-Q · filed 2020-04-28 | $294.40M derived: sum of 2 quarters · filed 2021-02-12 | $636.70M derived: sum of 3 quarters · filed 2021-02-12 | $776.90M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $292.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $635.20M derived: sum of 2 quarters · filed 2021-02-12 | $775.40M derived: sum of 3 quarters · filed 2021-02-12 | $926.70M 10-K · filed 2021-02-12 | $926.80M 10-K · filed 2019-02-15 | |||
| 2018-09-30 | $342.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $482.50M derived: sum of 2 quarters · filed 2019-10-25 | $633.80M 10-Q · filed 2019-10-25 | $997.70M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $140.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $291.50M 10-Q · filed 2019-07-26 | $655.40M derived: sum of 3 quarters · filed 2020-02-14 | $966.20M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $151.30M 10-Q · filed 2019-04-26 | $515.20M derived: sum of 2 quarters · filed 2020-02-14 | $826.00M derived: sum of 3 quarters · filed 2020-02-14 | $1.02B derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | $363.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $674.70M derived: sum of 2 quarters · filed 2020-02-14 | $872.40M derived: sum of 3 quarters · filed 2020-02-14 | $1.00B 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $310.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $508.50M derived: sum of 2 quarters · filed 2018-10-26 | $636.80M 10-Q · filed 2018-10-26 | |||||
| 2017-06-30 | $197.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $326.00M 10-Q · filed 2018-07-27 | ||||||
| 2017-03-31 | $128.30M 10-Q · filed 2018-04-27 | |||||||
| 2016-12-31 | $704.40M 10-K · filed 2019-02-15 | |||||||
| 2015-12-31 | $549.70M 10-K · filed 2018-02-16 | |||||||
| 2011-06-30 | $59.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $74.20M 10-Q · filed 2011-08-08 | $168.20M derived: sum of 3 quarters · filed 2011-08-08 | $264.60M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2011-03-31 | $14.90M 10-Q · filed 2011-05-09 | $108.90M derived: sum of 2 quarters · filed 2011-05-09 | $205.30M derived: sum of 3 quarters · filed 2011-05-09 | $253.30M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-12-31 | $94.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $190.40M derived: sum of 2 quarters · filed 2011-02-28 | $238.40M derived: sum of 3 quarters · filed 2011-08-08 | $251.40M 10-K · filed 2011-02-28 | ||||
| 2010-09-30 | $96.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $144.40M derived: sum of 2 quarters · filed 2011-08-08 | $157.40M 10-Q · filed 2010-11-08 | $223.30M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $61.00M 10-Q · filed 2011-08-08 | $126.90M derived: sum of 3 quarters · filed 2011-08-08 | $198.40M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-03-31 | $13.00M 10-Q · filed 2011-05-09 | $78.90M derived: sum of 2 quarters · filed 2011-05-09 | $150.40M derived: sum of 3 quarters · filed 2011-05-09 | |||||
| 2009-12-31 | $65.90M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $137.40M derived: sum of 2 quarters · filed 2011-02-28 | $165.30M 10-K · filed 2011-02-28 | |||||
| 2009-09-30 | $71.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $99.40M 10-Q · filed 2010-11-08 | ||||||
| 2009-06-30 | $27.90M 10-Q · filed 2010-08-06 | |||||||
| 2008-12-31 | $153.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |